SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001683168-23-006456
Filing Date
2023-09-15
Accepted
2023-09-14 19:29:33
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS sonoma_defa14a.htm DEFA14A 18580
2 GRAPHIC image_002.jpg GRAPHIC 3619
3 GRAPHIC image_001.jpg GRAPHIC 1780
  Complete submission text file 0001683168-23-006456.txt   27375
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEFA14A | Act: 34 | File No.: 001-33216 | Film No.: 231256269
SIC: 2834 Pharmaceutical Preparations